This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For survivors of strokes, regaining fine motor skills is critical for recovering independence and quality of life. But getting intensive, frequent rehabilitation therapy can be challenging and expensive.
Getty Images milla1cf Mon, 04/01/2024 - 08:21 April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number. “We What is Valvular Heart Disease?
Food and Drug Administration’s ( FDA ) Breakthrough Device Designation for their ECGvision-TTR Technology for early detection of ATTR-Cardiomyopathy. Moreover, ECGvision-TTR paves the way for personalized care plans, enhancing the quality of life for individuals at risk of or suffering from ATTR-CM.
This can lead to symptoms such as severe shortness of breath, swelling in the legs and abdomen and a significant reduction in quality of life. We have been eagerly anticipating the opportunity to bring this innovative technology to our community. The recent approval of the tricuspid clip device by the U.S.
Background and purpose:The aim of this study is to assess the impacts of digital health interventions on quality of life and mental status in stroke patients. A total of 17 studies involving 1437 participants were included.
Background This review aimed to compare the relative effectiveness of different exercise-based cardiac rehabilitation (ExCR) delivery modes (centre-based, home-based, hybrid and technology-enabled ExCR) on key heart failure (HF) outcomes: exercise capacity, health-related quality of life (HRQoL), HF-related hospitalisation and HF-related mortality.
CMS previously published a New Technology APC (Ambulatory Payment Classifications) code that covers the CardiAMP Cell Therapy investigational study procedure, including the BioCardia investigational products utilized to perform the study procedure, allowing the study centers to be reimbursed for the study procedure and products.
Heart failure (HF) is a growing worldwide public health issue affecting 64 million people annually 1 and is associated with high mortality, lower quality of life and reduced physical capacity while placing substantial costs on the healthcare system.
Dr. JoAnn Lindenfeld of Vanderbilt University presented analysis showing that patients with Barostim + GDMT had sustained and significant improvements in quality-of-life scores (MLWHF and EQ-5D) and many subdomains of these scores (e.g., See more details at TCTMD. versus patients on GDMT alone.
The IVI is working towards a transition to a new kind of wellness and health system fueled and empowered by digital technologies. This concept, reported the company, is about using technology to develop preventative approaches that are 10 times more impactful than the current available solution.
While the stenting of coronary lesions continues to show a substantial improvement in quality of life for patients with coronary artery disease, ISR still encompasses 10 percent of percutaneous coronary interventions in the U.S. Boston Scientific plans to launch the technology in the U.S. vs. 28.7%; P=0.006).
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Ultimately, the new device promises to enable excellent clinical outcomes and drive significant quality of life improvements.”
milla1cf Thu, 03/28/2024 - 07:30 March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration ( FDA ) has approved the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis.
million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.
Using multiple, serial, intravascular scaffolds, the patented FlexStep Technology combines flexibility with support to open clogged vessels and sustain healthy blood flow while accommodating tortuosity and skeletal movement. 2 An estimated 10% of patients with PAOD have its most severe form: chronic limb-threatening ischemia (CLTI).
These methods only alleviate symptoms of heart failure and myocardial ischemia and improve patients' quality of life by partially restoring myocardial reperfusion. The main content of this paper is to explore the application of stem cells and gene technology in the treatment of myocardial infarction (MI).
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
Recent technological advancements, such as catheter design and energy delivery, can pave the way for the wider adoption of PFA in clinical practice to improve patient outcomes. All patients in the study achieved acute success.
Submissions are especially welcome in the following areas: AI applications in diagnostic screening of cardiovascular diseases AI models for cardiovascular risk assessment • Development of AI-assisted technologies for cardiac procedures Impact of AI on clinical decision-making and personalized care for cardiovascular patients Economic and ethical analyses (..)
The results were divided into qualitative and quantitative outcomes.Conclusions:11 effect domains were defined: functional, psychological, burden, social, general health and self-efficacy, family function, quality of life, health care utilization, preparedness, quality of care and relationship to technology.
The aim of this study is to understand reasons for dropout in a stroke trial.Methods:The C3FIT (Coordinated, Collaborative, Comprehensive Family-Based, Integrated, Technology-enabled Care) (NCT04000971) is a multicenter, randomized, single-blinded, Phase III, cluster randomized trial assessing if an Integrated Stroke Practice Unit (ISPU) system of (..)
Key secondary and exploratory outcomes include improvement in a composite cardiovascular health metric, CR engagement, quality of life, health factors (including low‐density lipoprotein‐cholesterol, hemoglobin A1c, weight, diet, smoking cessation, blood pressure), and psychosocial factors.
Digital technologies may reveal it is even more common than the current analysis indicates. Fortunately, atrial fibrillation is preventable, and early detection and appropriate treatment can substantially reduce its adverse outcomes,” he said. Marcus, MD, MAS, a cardiologist and electrophysiologist at UCSF Health.
Cardiorenal and metabolic diseases represent a complex constellation of lifestyle factors and health conditions that significantly impact longevity and quality of life. Accessibility: Addressing the cost and availability of advanced technologies to ensure widespread access to precision nutrition. What are omics technologies?
Cardiomatics is thrilled to announce a groundbreaking partnership with BIOTRONIK, a leading global medical technology company specialising in heart and blood vessel diseases as well as chronic pain. “I am excited about the potential of AI to help early detection of cardiac rhythm abnormalities. ” – says Rafa Samborski.
This randomised study set out to examine if smartphone-based app technology could increase weight loss in a patient population with obesity and AF. Final follow-up at six months included clinical and weight data and a quality-of-life questionnaire. Sixty-four patients underwent randomisation.
We now have one more technology, on the verge of approval by the FDA. Final message WiSE CRT uses some revolutionary technology and it is a welcome addition in few eligible patients. However, advanced heart failure therapy never means it can be achieved only by state-of-the-art technology. 2021 May 21;23(5):740-747.
milla1cf Wed, 02/28/2024 - 19:59 February 28, 2024 — Royal Philips , a global leader in health technology, announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system.
We’re thrilled to partner with Athletic Heart to provide valuable medical insights to clinicians and athletes that can ultimately improve their quality of life and brain health,” said Maria Sainz , president and CEO of Hyperfine, Inc. Hyperfine, Inc.
National and international cardiac organisations recommend all patients use this technology, however patient engagement is suboptimal. Introduction Cardiac implantable electronic devices (CIED) can transfer data to the healthcare team, remotely. A sample size of 100 will have a 90% power to detect a minimum difference of 1.07
Submissions are especially welcome in the following areas: AI applications in diagnostic screening of cardiovascular diseases AI models for cardiovascular risk assessment • Development of AI-assisted technologies for cardiac procedures Impact of AI on clinical decision-making and personalized care for cardiovascular patients Economic and ethical analyses (..)
Geisinger is at the forefront of research and technological advancements that allow for better patient outcomes and improvements in their quality of life.” Cardiac amyloidosis is caused by protein buildup between the muscle cells of the heart, increasing the thickness of the heart.
It also plays a significant role in overcoming interoperability challenges by providing a platform compatible with various technologies, educating staff on the benefits of interoperability, and implementing industry-wide standards for data formats and communication protocols.
At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cutting-edge Computed Tomography (CT) and Cardiac MRI technologies are transforming this domain, offering unprecedented insights into the intricate workings of the heart and vascular system.
At the forefront of this quest lie the remarkable advancements in imaging technology, ushering in a new era of precision and insight. Cutting-edge Computed Tomography (CT) and Cardiac MRI technologies are transforming this domain, offering unprecedented insights into the intricate workings of the heart and vascular system.
Our upcoming session is just around the corner, and we've gathered all the crucial information you need to stay at the forefront of this game-changing technology. Speedy Recovery: Patients experience a faster recuperation and an improved quality of life. Look no further!
Technological innovations have made catheter ablation safer and more effective than ever before,” Tzeis, who added, “For example, we now have pulsed field ablation which uses high energy electrical pulses to treat atrial fibrillation without damaging the nerves or oesophagus. The risk of death is extremely low (0.05-0.1%).
mid-term (three-year) data results demonstrated superior patient outcomes with positive sustained RV remodeling, effective valve function, and a strong safety profile, all contributing to significant improvement in patient quality of life. Harmony TPV U.S. For more information, please visit www.Medtronic.com. 1 Hoffman JL, Kaplan S.
ii The DEFINE AFib clinical study enrolled 973 patients using an app-based enrollment feature and characterized the impact of AF burden on patient outcomes and quality of life. By 2030, approximately 12.2 million people in the U.S. will have AF, an irregular and potentially dangerous heart rhythm.
The opportunity to treat the hearts of pediatric patients with our life-supporting technology is incredible and fills us with gratitude," saidSonya Bhavsar, PhD, Senior Director, R&D, ECP & Pediatrics Platform, Heart Recovery, Johnson & Johnson MedTech. with SmartAssist has been expanded as follows: The Impella 5.5
“I’ve seen the compelling clinical evidence on Carillon therapy from Europe and look forward to helping the team expand the supportive body of evidence for this intriguing technology with the U.S. pivotal EMPOWER Trial,” said Dr. Shreenivas. “I
It also plays a significant role in overcoming interoperability challenges by providing a platform compatible with various technologies, educating staff on the benefits of interoperability, and implementing industry-wide standards for data formats and communication protocols.
Advancements in medical technology have revolutionized the diagnosis and treatment of heart diseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. Startups are developing image analytics solutions using deep learning technologies to improve patient outcomes.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content